MedTrace Logo

Effects of a Female Hormone Balance Supplement on Premenstrual Syndrome Symptoms

NCT07018479 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2025-06-12

No results posted yet for this study

Summary

This virtual single-group study evaluates the effects of the FemmeBalance supplement on symptoms of premenstrual syndrome (PMS) over four menstrual cycles. The study involves daily intake of the supplement, regular questionnaires, and skin photo submissions for dermatological grading.

Conditions

  • Premenstrual Syndrome

Interventions

DIETARY_SUPPLEMENT

FemmeBalance Supplement Group

Participants will take two capsules daily of the FemmeBalance supplement with their evening meal for four menstrual cycles

Sponsors & Collaborators

  • Citruslabs

    collaborator INDUSTRY

  • VINABAS FORMULATIONS SL

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-30
Primary Completion
2025-01-20
Completion
2025-01-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07018479 on ClinicalTrials.gov